Back
HFA Premium Access

QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study

Session: Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor A. Pozzi (Como, IT)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Andrea Pozzi

Hospital Valduce, Como (Italy)
0 follower

22 more presentations in this session

Nationwide trends in prevalence and incidence of and 3-year mortality in hospitalized heart failure patients in Taiwan (2010-2015): lingering hazards remain

Speaker: Professor T. Wang (Taipei, TW)

Access
Abstract
Slides
Like
Thumbnail

Modes of death in cardiac amyloidosis

Speaker: Ms C. Binder (Vienna, AT)

Access
Abstract
Like
Thumbnail

Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure

Speaker: Doctor S. Stojkovic (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Genetics in heart failure prognosis: does it make a difference?

Speaker: Mr A. Ulitin (Saint Petersburg, RU)

Access
Abstract
Slides
Like
Thumbnail

Economic impact of ivabradine use in the vulnerable phase: results from the ROCI registry

Speaker: Professor C. Saldarriaga Giraldo (Medellin, CO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 1 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Speakers: Doctor A. Pozzi, Professor T. Wang, Ms C. Binder, Doctor S. Stojkovic, Mr A. Ulitin...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources